Skip to content
2000
Volume 5, Issue 1
  • ISSN: 2950-4023
  • E-ISSN: 2950-4031

Abstract

As of mid-2024, researchers had identified approximately 85,000 instances of the monkeypox virus (MPXV), posing a serious hazard to public health. This letter offers a thorough analysis of the available antiviral treatments, emphasizing tecovirimat as the main course of action. Disparities in access continue despite its shown efficacy, which raises death rates in endemic areas, such as sub-Saharan Africa. The use of two further potential therapies, brincidofovir and cidofovir, has been limited due to toxicity concerns. The letter also calls for increased clinical research, equitable antiviral medication distribution, and combination therapy studies to address rising drug resistance.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctc/10.2174/0129504023356775250304083029
2025-01-01
2025-10-25

  • From This Site

    /content/journals/ctc/10.2174/0129504023356775250304083029
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SahR. MohantyA. HadaV. SinghP. GovindaswamyA. SiddiqA. RedaA. DhamaK. The emergence of monkeypox: A global health threat.Cureus2022149e2930410.7759/cureus.2930436277578
     [Google Scholar]
  2. IslamM.A. MuminJ. HaqueM.M. HaqueM.A. KhanA. BhattacharyaP. HaqueM.A. Monkeypox virus (MPXV): A Brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions.Infect. Med.20232426227210.1016/j.imj.2023.11.00138205182
     [Google Scholar]
  3. JohriN. KumarD. NagarP. MauryaA. VengatM. JainP. Clinical manifestations of human monkeypox infection and implications for outbreak strategy.Health Sci. Rev.2022510005510.1016/j.hsr.2022.10005536254190
     [Google Scholar]
  4. NakhriryM.A. Evaluating monkeypox transmission dynamics: Implications for public health interventions.Eigenpub Rev. Sci. Technol.2023717184
     [Google Scholar]
  5. GhoshN. ChackoL. VallamkonduJ. BanerjeeT. SarkarC. SinghB. KalraR.S. BhattiJ.S. KandimallaR. DewanjeeS. Clinical strategies and therapeutics for human monkeypox virus: A revised perspective on recent outbreaks.Viruses2023157153310.3390/v1507153337515218
     [Google Scholar]
  6. DeLaurentisC.E. KiserJ. ZuckerJ. New perspectives on antimicrobial agents: Tecovirimat for treatment of human monkeypox virus.Antimicrob. Agents Chemother.20226612e01226-2210.1128/aac.01226‑2236374026
     [Google Scholar]
  7. RussoA.T. GrosenbachD.W. ChinsangaramJ. HoneychurchK.M. LongP.G. LovejoyC. MaitiB. MearaI. HrubyD.E. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.Expert Rev. Anti Infect. Ther.202119333134410.1080/14787210.2020.181979132882158
     [Google Scholar]
  8. GrosenbachD.W. HoneychurchK. RoseE.A. ChinsangaramJ. FrimmA. MaitiB. LovejoyC. MearaI. LongP. HrubyD.E. Oral tecovirimat for the treatment of smallpox.N. Engl. J. Med.20183791445310.1056/NEJMoa170568829972742
     [Google Scholar]
  9. KarmarkarE.N. GoldenM.R. KeraniR.P. PogosjansS. ChowE.J. Bender IgnacioR.A. RamchandaniM.S. KayM.K. CannonC.A. DombrowskiJ.C. In Association of tecovirimat therapy with mpox symptom improvement: A cross-sectional study—King County, Washington, May–October 2022.Open Forum Infect. Dis.2024113ofae02910.1093/ofid/ofae02938456195
     [Google Scholar]
  10. MatiasW.R. KoshyJ.M. NagamiE.H. KovacV. MoengL.R. ShenoyE.S. HooperD.C. MadoffL.C. BarshakM.B. JohnsonJ.A. RowleyC.F. JulgB. HohmannE.L. LazarusJ.E. In Tecovirimat for the treatment of human monkeypox: An initial series from Massachusetts, United States.Open Forum Infect. Dis.202298ofac37710.1093/ofid/ofac37735949403
     [Google Scholar]
  11. SiegristE.A. SassineJ. Antivirals with activity against mpox: A clinically oriented review.Clin. Infect. Dis.202376115516410.1093/cid/ciac62235904001
     [Google Scholar]
  12. ImranM. AlshammariM.K. AroraM.K. DubeyA.K. DasS.S. KamalM. AlqahtaniA.S.A. SahlolyM.A.Y. AlshammariA.H. AlhomamH.M. MahzariA.M. Abida RabaanA.A. DzinamariraT. Oral brincidofovir therapy for monkeypox outbreak: A focused review on the therapeutic potential, clinical studies, patent literature, and prospects.Biomedicines202311227810.3390/biomedicines1102027836830816
     [Google Scholar]
  13. PasikhovaY. Antiviral agents: Cidofovir and brincidofovir.Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century.Springer2024251277
     [Google Scholar]
  14. AndreiG. SnoeckR. Cidofovir and Brincidofovir.Kucers’ The Use of Antibiotics.CRC Press201735313571
     [Google Scholar]
  15. PrévostJ. SloanA. DeschambaultY. TailorN. TierneyK. AzaranskyK. KammanadimintiS. BarkerD. KodihalliS. SafronetzD. Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates.Antiviral Res.202423110599510.1016/j.antiviral.2024.10599539243894
     [Google Scholar]
  16. LeeW. KimY.J. LeeS.J. AhnD.G. KimS.J. Current status of epidemiology, diagnosis, therapeutics, and vaccines for the re-emerging human monkeypox virus.J. Microbiol. Biotechnol.202333898199110.4014/jmb.2306.0603337519276
     [Google Scholar]
  17. MalikS. AhmadT. AhsanO. MuhammadK. WaheedY. Recent developments in mpox prevention and treatment options.Vaccines202311350010.3390/vaccines1103050036992085
     [Google Scholar]
  18. HughesL.J. GoldsteinJ. PohlJ. HooperJ.W. Lee PittsR. TownsendM.B. BagarozziD. DamonI.K. KaremK.L. A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27.Virology2014464-46526427310.1016/j.virol.2014.06.03925108113
     [Google Scholar]
  19. WangY. YangK. ZhouH. Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review.Int. J. Biol. Macromol.202324512551510.1016/j.ijbiomac.2023.12551537353117
     [Google Scholar]
  20. ZhuW. ZhangM. ZhangM. JingR. ZhouJ. CaoH. LiuC. ZhuH. GhonaimA.H. RoubyS.R. LiW. The generation and characterization of monoclonal antibodies against the MPXV A29L protein.Viruses2024168118410.3390/v1608118439205158
     [Google Scholar]
  21. WHO declares mpox outbreak a public health emergency of international concern.Eurosurveillance20242933240815v
     [Google Scholar]
  22. McQuistonJ.H. LuceR. KazadiD.M. BwanganduC.N. Mbala-KingebeniP. AndersonM. PrasherJ.M. WilliamsI.T. PhanA. ShelusV. BratcherA. SokeG.N. FonjungoP.N. KabambaJ. McCollumA.M. PerryR. RaoA.K. DotyJ. ChristensenB. FullerJ.A. BairdN. ChaitramJ. BrownC.K. KirbyA.E. FitterD. FolsterJ.M. DualehM. HartmanR. BartS.M. HughesC.M. NakazawaY. SimsE. ChristieA. HutsonC.L. CDC 2024 Clade I Mpox Response Team US preparedness and response to increasing clade I mpox cases in the Democratic Republic of the Congo—United States, 2024.MMWR Morb. Mortal. Wkly. Rep.2024731943544010.15585/mmwr.mm7319a338753567
     [Google Scholar]
  23. MoyoE. MusukaG. MurewanhemaG. MoyoP. DzinamariraT. Monkeypox outbreak: A perspective on Africa’s diagnostic and containment capacity.Int. J. Infect. Dis.202212312713010.1016/j.ijid.2022.08.01636007687
     [Google Scholar]
  24. ShamimM.A. PadhiB.K. SatapathyP. VeeramachaneniS.D. ChatterjeeC. TripathyS. AkhtarN. PradhanA. DwivediP. MohantyA. Rodriguez-MoralesA.J. SahR. Al-TammemiA.B. Al-TawfiqJ.A. Nowrouzi-KiaB. ChattuV.K. The use of antivirals in the treatment of human monkeypox outbreaks: A systematic review.Int. J. Infect. Dis.202312715016110.1016/j.ijid.2022.11.04036470502
     [Google Scholar]
  25. MohantoS. FaiyazuddinM. Dilip GholapA. JcD. BhuniaA. SubbaramK. Gulzar AhmedM. NagS. Shabib AkhtarM. Bonilla-AldanaD.K. SahS. MalikS. Haleem Al-qaimZ. BarbozaJ.J. SahR. Addressing the resurgence of global monkeypox (Mpox) through advanced drug delivery platforms.Travel Med. Infect. Dis.20235610263610.1016/j.tmaid.2023.10263637633474
     [Google Scholar]
  26. FoxT. GouldS. PrincyN. RowlandT. LutjeV. KuehnR. KuehnR. Therapeutics for treating mpox in humans.Cochrane Database Syst. Rev.202333CD01576936916727
     [Google Scholar]
/content/journals/ctc/10.2174/0129504023356775250304083029
Loading

  • Article Type:     Editorial
Keyword(s): antiviral agents; brincidofovir; global health crisis; Monkeypox virus (MPXV); orthopoxvirus; tecovirimat
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test